Association between human Epstein–Barr virus and brain cancer: a systematic review and meta-analysis

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Ghorbani S, Letafati A, Khatami A et al. Association between human herpesvirus-6 and primary brain tumors: a systematic review and meta-analysis. Future Virol. 17(5), 305–314 (2022).
  CASGoogle Scholar
• 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J. Clin. 69(1), 7–34 (2019). • The review covers information on cancer statistics in the world.
  MedlineGoogle Scholar
• 3. Akhtar S, Vranic S, Cyprian FS, Al Moustafa A-E. Epstein–Barr virus in gliomas: cause, association, or artifact? Front. Oncol. 8, 123 (2018). • The review provides information about Epstein–Barr virus (EBV) association with glioma.
  MedlineGoogle Scholar
• 4. Bouza E, Jiménez MM, Alemany L et al. Overview of virus and cancer relationships. Position paper. Rev. Esp. Quimioter. 34(6), 525–555 (2021).
  Medline CASGoogle Scholar
• 5. Farahmand M, Monavari SH, Shoja Z, Ghaffari H, Tavakoli M, Tavakoli A. Epstein–Barr virus and risk of breast cancer: a systematic review and meta-analysis. Future Oncol. 15(24), 2873–2885 (2019).
  CASGoogle Scholar
• 6. Tavakoli A, Monavari SH, Mohammadi FS, Kiani SJ, Armat S, Farahmand M. Association between Epstein–Barr virus infection and gastric cancer: a systematic review and meta-analysis. BMC Cancer 20(1), 1–14 (2020).
  Google Scholar
• 7. de Lima MAP, Neto PJN, Lima LPM et al. Association between Epstein–Barr virus (EBV) and cervical carcinoma: a meta-analysis. Gynecol. Oncol. 148(2), 317–328 (2018).
  MedlineGoogle Scholar
• 8. Vedham V, Verma M, Mahabir S. Early-life exposures to infectious agents and later cancer development. Cancer Med. 4(12), 1908–1922 (2015).
  MedlineGoogle Scholar
• 9. Vockerodt M, Yap LF, Shannon-Lowe C et al. The Epstein–Barr virus and the pathogenesis of lymphoma. J. Pathol. 235(2), 312–322 (2015).
  MedlineGoogle Scholar
• 10. Page MJ, Moher D. Evaluations of the uptake and impact of the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and extensions: a scoping review. Syst. Rev. 6(1), 1–14 (2017).
  MedlineGoogle Scholar
• 11. Fonseca RF, Rosas SLB, Oliveira JA, Teixeira A, Alves G, da Glória Costa Carvalho M. Frequency of Epstein–Barr virus DNA sequences in human gliomas. Sao Paulo Med. J. 133, 51–54 (2015). •• Evaluates the EBV infection in glioma patients.
  MedlineGoogle Scholar
• 12. Hashida Y, Taniguchi A, Yawata T et al. Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect. Agents Cancer 10(1), 1–9 (2015).
  MedlineGoogle Scholar
• 13. Strojnik T, Duh D, Lah TT. Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential. In Vivo 31(2), 221–229 (2017).
  Medline CASGoogle Scholar
• 14. Limam S, Missaoui N, Bdioui A et al. Investigation of simian virus 40 (SV40) and human JC, BK, MC, KI, and WU polyomaviruses in glioma. J. Neurovirol. 26(3), 347–357 (2020).
  Medline CASGoogle Scholar
• 15. Zavala-Vega S, Castro-Escarpulli G, Hernández-Santos H et al. An overview of the infection of CMV, HSV 1/2 and EBV in Mexican patients with glioblastoma multiforme. Pathol. Res. Pract. 213(3), 271–276 (2017).
  Medline CASGoogle Scholar
• 16. Teruel-Martí V, Cervera-Ferri A, Nuñez A, Valverde-Navarro AA, Olucha-Bordonau FE, Ruiz-Torner A. Anatomical evidence for a ponto-septal pathway via the nucleus incertus in the rat. Brain Res. 1218, 87–96 (2008).
  Medline CASGoogle Scholar
• 17. Chi J, Gu B, Zhang C et al. Human herpesvirus 6 latent infection in patients with glioma. J. Infect. Dis. 206(9), 1394–1398 (2012).
  Medline CASGoogle Scholar
• 18. Saglam A, Akyurek N, Soylemezoglu F, Uner A. Epstein–Barr virus frequency in primary central nervous system lymphomas in Turkey. APMIS 121(3), 232–238 (2013).
  MedlineGoogle Scholar
• 19. Strong MJ, Blanchard ET, Lin Z et al. A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association. Acta Neuropathol. Commun. 4(1), 71 (2016).
  MedlineGoogle Scholar
• 20. Cimino PJ, Zhao G, Wang D, Sehn JK, Lewis JS Jr, Duncavage EJ. Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data. Exp. Mol. Pathol. 96(3), 310–315 (2014).
  Medline CASGoogle Scholar
• 21. Ghaffari H, Tavakoli A, Faranoush M et al. Molecular investigation of human cytomegalovirus and Epstein–Barr virus in glioblastoma brain tumor: a case–control study in Iran. Iranian Biomed. J. 25(6), 426 (2021).
  MedlineGoogle Scholar
• 22. Lin C-TM, Leibovitch EC, Almira-Suarez MI, Jacobson S. Human herpesvirus multiplex ddPCR detection in brain tissue from low-and high-grade astrocytoma cases and controls. Infect. Agents Cancer 11(1), 1–10 (2016).
  MedlineGoogle Scholar
• 23. Cosset É, Petty TJ, Dutoit V et al. Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int. J. Cancer 135(6), 1381–1389 (2014).
  Medline CASGoogle Scholar
• 24. Khoury JD, Tannir NM, Williams MD et al. Landscape of DNA Virus Associations across human malignant cancers: analysis of 3775 cases using RNA-Seq. J. Virol. 87(16), 8916–8926 (2013). •• Compares the herpes viruses among low and high grad astrocytoma patients and controls.
  Medline CASGoogle Scholar
• 25. Münz C. Latency and lytic replication in Epstein–Barr virus-associated oncogenesis. Nat. Rev. Microbiol. 17(11), 691–700 (2019). • Provides information on the mechanisms of EBV carcinogenesis.
  MedlineGoogle Scholar
• 26. Yue W, Zhu M, Zuo L et al. Early pattern of Epstein–Barr virus infection in gastric epithelial cells by “cell-in-cell”. Virol. Sin. 34(3), 253–261 (2019).
  Medline CASGoogle Scholar
• 27. Schneider F, Neugebauer J, Griese J et al. The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity. PLoS Biol. 6(1), e8 (2008).
  MedlineGoogle Scholar
• 28. Ahsan N, Kanda T, Nagashima K, Takada K. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J. Virol. 79(7), 4415–4424 (2005).
  Medline CASGoogle Scholar
• 29. Murata T, Sato Y, Kimura H. Modes of infection and oncogenesis by the Epstein–Barr virus. Rev. Med. Virol. 24(4), 242–253 (2014).
  Medline CASGoogle Scholar
• 30. Mui UN, Haley CT, Tyring SK. Viral oncology: molecular biology and pathogenesis. J. Clin. Med. 6(12), 111 (2017).
  MedlineGoogle Scholar
• 31. Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein–Barr virus infections. Clin. Microbiol. Rev. 24(1), 193–209 (2011).
  Medline CASGoogle Scholar
• 32. Khalil M, Enzinger C, Wallner-Blazek M et al. Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient. J. Neurovirol. 14(6), 574–578 (2008).
  MedlineGoogle Scholar
• 33. Fujimoto H, Asaoka K, Imaizumi T, Ayabe M, Shoji H, Kaji M. Epstein–Barr virus infections of the central nervous system. Intern. Med. 42(1), 33–40 (2003). •• Provides useful information about EBV infection in CNS.
  MedlineGoogle Scholar
• 34. Gasque P, Chan P, Mauger C et al. Identification and characterization of complement C3 receptors on human astrocytes. J. Immunol. 156(6), 2247–2255 (1996).
  Medline CASGoogle Scholar
• 35. Menet A, Speth C, Larcher C et al. Epstein-Barr virus infection of human astrocyte cell lines. J. Virol. 73(9), 7722–7733 (1999).
  Medline CASGoogle Scholar
• 36. Sugita Y, Muta H, Ohshima K et al. Primary central nervous system lymphomas and related diseases: pathological characteristics and discussion of the differential diagnosis. Neuropathology 36(4), 313–324 (2016).
  MedlineGoogle Scholar
• 37. Aksamit AJ. Treatment of viral encephalitis. Neurol. Clin. 39(1), 197–207 (2021).
  MedlineGoogle Scholar
• 38. Hedström AK, Huang J, Brenner N et al. Smoking and Epstein–Barr virus infection in multiple sclerosis development. Sci.Rep. 10(1), 10960 (2020).
  MedlineGoogle Scholar
• 39. Tiwari D, Singh VK, Baral B et al. Indication of neurodegenerative cascade initiation by amyloid-like aggregate-forming EBV proteins and peptide in Alzheimer's disease. ACS Chem. Neurosci. 12(20), 3957–3967 (2021).
  Medline CASGoogle Scholar
• 40. Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr virus and neurological diseases. Front. Mol. Biosci. 8, 1310 (2022).
  Google Scholar
• 41. Khalesi Z, Tamrchi V, Razizadeh MH et al. Association between human herpesviruses and multiple sclerosis: a systematic review and meta-analysis. Microb.Pathog. 177, 106031 (2023).
  Medline CASGoogle Scholar